Patents by Inventor Saumitra Bagchi

Saumitra Bagchi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11452701
    Abstract: In one aspect, the present invention features an emulsion composition including (i) at least 3%, by weight, of a nonsteroidal anti-inflammatory drug; (ii) at least 15%, by weight, of isopropyl myristate; (iii) at least 25%, by weight, of water; and (iv) one or more emulsifiers; wherein the formulation is substantially free of C1-C4 alcohols.
    Type: Grant
    Filed: November 28, 2018
    Date of Patent: September 27, 2022
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Saumitra Bagchi, Donald Hasenmayer
  • Publication number: 20190224129
    Abstract: The present invention relates to gelatin capsules containing microbeads. The capsule has perforations that enhance the dissolution of the capsule.
    Type: Application
    Filed: January 7, 2019
    Publication date: July 25, 2019
    Inventors: Saumitra Bagchi, Gerard P. McNally
  • Publication number: 20190167616
    Abstract: In one aspect, the present invention features an emulsion composition including (i) at least 3%, by weight, of a nonsteroidal anti-inflammatory drug; (ii) at least 15%, by weight, of isopropyl myristate; (iii) at least 25%, by weight, of water; and (iv) one or more emulsifiers; wherein the formulation is substantially free of C1-C4 alcohols.
    Type: Application
    Filed: November 28, 2018
    Publication date: June 6, 2019
    Inventors: Saumitra Bagchi, Donald Hasenmayer
  • Patent number: 10022349
    Abstract: Cadotril particles suitable for solid or liquid dosage forms are the subject of this application.
    Type: Grant
    Filed: October 29, 2015
    Date of Patent: July 17, 2018
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Saumitra Bagchi, Murali K. Vuppala
  • Publication number: 20160120834
    Abstract: Cadotril particles suitable for solid or liquid dosage forms are disclosed
    Type: Application
    Filed: October 29, 2015
    Publication date: May 5, 2016
    Inventors: Saumitra Bagchi, Murali K. Vuppala
  • Publication number: 20160051678
    Abstract: Low melting propionic acid derivative particles that are free flowing and have significantly reduced or eliminated throat burn are disclosed. A method of manufacturing the low melting propionic acid derivative particles; dosage forms containing the low melting propionic acid derivative particles; methods of manufacturing the dosage forms; and methods of treatment using the dosage forms are also disclosed.
    Type: Application
    Filed: August 27, 2015
    Publication date: February 25, 2016
    Inventors: Saumitra Bagchi, Murali K. Vuppala
  • Patent number: 9259394
    Abstract: A dosage form comprising a tablet core containing at least one active ingredient and having at least one modified release coating that partially surrounds the tablet core is disclosed. The tablet core is preferably in the form of a compressed core wherein the at least one modified release coating is provided on a position of the exterior surface of the compressed core using dipping technology. The invention also relates to a method of manufacturing the dosage form and a method of treatment using the dosage form.
    Type: Grant
    Filed: December 7, 2010
    Date of Patent: February 16, 2016
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Saumitra Bagchi, Murali Vuppala
  • Publication number: 20140256810
    Abstract: Low melting propionic acid derivative particles that are free flowing and have significantly reduced or eliminated throat burn are disclosed. A method of manufacturing the low melting propionic acid derivative particles; dosage forms containing the low melting propionic acid derivative particles; methods of manufacturing the dosage forms; and methods of treatment using the dosage forms are also disclosed.
    Type: Application
    Filed: March 8, 2013
    Publication date: September 11, 2014
    Applicant: MCNEIL-PPC, INC.
    Inventors: Saumitra Bagchi, Murali K. Vuppala
  • Publication number: 20140213653
    Abstract: A compressed tablet containing directly compressible propionic acid derivative particles is disclosed. A method of manufacturing a compressed tablet containing the directly compressible propionic acid derivative particles; and methods of treatment using the compressed tablet are also disclosed.
    Type: Application
    Filed: March 28, 2014
    Publication date: July 31, 2014
    Applicant: McNeil-PPC, Inc.
    Inventors: Saumitra Bagchi, Murali K. Vuppala
  • Publication number: 20140080912
    Abstract: Low melting propionic acid derivative particles that are free flowing and have significantly reduced or eliminated throat burn are disclosed. A method of manufacturing the low melting propionic acid derivative particles; dosage forms containing the low melting propionic acid derivative particles; methods of manufacturing the dosage forms; and methods of treatment using the dosage forms are also disclosed.
    Type: Application
    Filed: September 16, 2013
    Publication date: March 20, 2014
    Applicant: McNeil-PPC, Inc.
    Inventors: Saumitra Bagchi, Murali K. Vuppala
  • Publication number: 20140079796
    Abstract: Low melting propionic acid derivative particles that are free flowing and have significantly reduced or eliminated throat burn are disclosed. A method of manufacturing the low melting propionic acid derivative particles; dosage forms containing the low melting propionic acid derivative particles; methods of manufacturing the dosage forms; and methods of treatment using the dosage forms are also disclosed.
    Type: Application
    Filed: September 16, 2013
    Publication date: March 20, 2014
    Applicant: McNeil-PPC, Inc.
    Inventors: Saumitra Bagchi, Murali K. Vuppala
  • Publication number: 20110135694
    Abstract: A dosage form comprising a tablet core containing at least one active ingredient and having at least one modified release coating that partially surrounds the tablet core is disclosed. The tablet core is preferably in the form of a compressed core wherein the at least one modified release coating is provided on a position of the exterior surface of the compressed core using dipping technology. The invention also relates to a method of manufacturing the dosage form and a method of treatment using the dosage form.
    Type: Application
    Filed: December 7, 2010
    Publication date: June 9, 2011
    Inventors: Saumitra Bagchi, Murali Vuppala